Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias

Biomaterials

Volumn 34, Issue 35, 2013, Pages 8878-8886

  Wang, Jiaxian ^a,b   Chen, Aaron ^d   Lieu, Deborah K ^b   Karakikes, Ioannis ^b   Chen, Gaopeng ^a,b   Keung, Wendy ^a   Chan, Camie W ^a   Hajjar, Roger J ^b   Costa, Kevin D ^b   Khine, Michelle ^c,d   Li, Ronald A ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c University of California at Irvine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anisotropy; Arrhythmias; Human embryonic stem cells; Reentry; Ventricular cardiomyocytes

Indexed keywords

ARRHYTHMIAS; CARDIOMYOCYTES; ELECTRICAL CONDUCTION; ELECTRICAL STABILITY; EMBRYONIC STEM CELLS; EXPERIMENTAL PLATFORM; HUMAN EMBRYONIC STEM CELLS; PLURIPOTENT STEM CELLS;

BIOMIMETICS; DIAGNOSIS; ELECTRIC PROPERTIES; ELECTROPHYSIOLOGY; PHYSIOLOGICAL MODELS; REENTRY; REPAIR; STEM CELLS;

ANISOTROPY;

ANISOTROPY; ARRHYTHMOGENESIS; ARTICLE; BIOMIMETICS; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN CELL; NERVE CONDUCTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; TISSUE ENGINEERING;

ANISOTROPY; ARRHYTHMIAS; HUMAN EMBRYONIC STEM CELLS; REENTRY; VENTRICULAR CARDIOMYOCYTES;

ANISOTROPY; ARRHYTHMIAS, CARDIAC; BIOMIMETIC MATERIALS; CELL DIFFERENTIATION; CELLS, CULTURED; ELECTROPHYSIOLOGICAL PHENOMENA; HEART VENTRICLES; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84883234192     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.039     Document Type: Article

References (36)

1. Cantillon D.J., Bianco C., Wazni O.M., Kani M., Smedira N.G., Wilkoff B.L., et al. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm 2012, 9:859-864.
2. Jalife J., Anumonwo J.M., Berenfeld O. Toward an understanding of the molecular mechanisms of ventricular fibrillation. JInterv Card Electrophysiol 2003, 9:119-129.
3. Burridge P.W., Anderson D., Priddle H., Barbadillo Munoz M.D., Chamberlain S., Alleqrucci C., et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 2007, 25:929-938.
4. Foley A.C., Gupta R.W., Guzzo R.M., Korol O., Mercola M. Embryonic heart induction. Ann NY Acad Sci 2006, 1080:85-96.
5. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
6. Poon E., Kong C.W., Li R.A. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharmacol 2011, 8:1495-1504.
7. Arbel G., Caspi O., Huber I., Gepstein A., Weiler-Saqie M., Gepstain L. Methods for human embryonic stem cells derived cardiomyocytes cultivation, genetic manipulation, and transplantation. Methods Mol Biol 2010, 660:85-95.
8. Gepstein L., Ding C., Rahmutula D., Wilson E.E., Yankelson L., Caspi O., et al. Invivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 2010, 28:2151-2161.
9. Kong C.W., Akar F.G., Li R.A. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: Insights from experimental models. Thromb Haemostasis 2010, 104:30-38.
10. Lieu D.K., Fu J.D., Chiamvimonvat N., Tung K.C., McNerney G.P., Huser T., et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 2013, 6:191-201.
11. Xu X.Q., Soo S.Y., Sun W., Zweigerdt R. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 2009, 27:2163-2174.
12. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111:11-20.
13. Zhu W.Z., Santana L.F., Laflamme M.A. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 2009, 4:e5407.
14. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003, 93:32-39.
15. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., Van Den Brink S., Hassink R., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
16. Siu C.W., Lieu D.K., Li R.A. HCN-encoded pacemaker channels: from physiology and biophysics to bioengineering. JMembr Biol 2006, 214:115-122.
17. Allessie M.A., Schalij M.J., Kirchhof C.J., Boersma L., Huybers M., Hollen J. Experimental electrophysiology and arrhythmogenicity. Anisotropy and ventricular tachycardia. Eur Heart J 1989, 10(Suppl.E):2-8.
18. Fast V.G., Darrow B.J., Saffitz J.E., Kleber A.G. Anisotropic activation spread in heart cell monolayers assessed by high-resolution optical mapping. Role of tissue discontinuities. Circ Res 1996, 79:115-127.
19. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., Gepstein L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel invitro model for the study of conduction. Circ Res 2002, 91:659-661.
20. Luna J.I., Ciriza J., Garcia-Ojeda M.E., Kong M., Herren A., Lieu D.K., et al. Multiscale biomimetic topography for the alignment of neonatal and embryonic stem cell-derived heart cells. Tissue Eng Part C Methods 2011, 17:579-588.
21. Moore J.C., Fu J., Chan Y.C., Lin D., Tran H., Tse H.F., et al. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun 2008, 372:553-558.
22. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
23. Tse H.F., Xue T., Lau C.P., Siu C.W., Wang K., Zhang Q.Y., et al. Bioartificial sinus node constructed via invivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation 2006, 114:1000-1011.
24. Kleber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004, 84:431-488.
25. Saffitz J.E., Kanter H.L., Green K.G., Tolley T.K., Bever E.C. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 1994, 74:1065-1070.
26. Samie F.H., Jalife J. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart. Cardiovasc Res 2001, 50:242-250.
27. Bettinger C.J., Langer R., Borenstein J.T. Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl 2009, 48:5406-5415.
28. Bowden N., Brittain S., Evans A.G., Hutchinson J.W., Whitesides G.M. Spontaneous formation of ordered structures in thin films of metals supported on an elastomeric polymer. Nature 1998, 393:146-149.
29. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
30. Jiang X., Takayama S., Qian X., Ostuni E., Wu H., Bowden N., et al. Controlling mammalian cell spreading and cytoskeletal arrangement with conveniently fabricated continuous wavy features on poly(dimethylsiloxane). Langmuir 2002, 18:3273-3280.
31. Lam M.T., Clem W.C., Takayama S. Reversible on-demand cell alignment using reconfigurable microtopography. Biomaterials 2008, 29:1705-1712.
32. Nathan A.S., Baker B.M., Nerurkar N.L., Mauck R.L. Mechano-topographic modulation of stem cell nuclear shape on nanofibrous scaffolds. Acta Biomater 2011, 7:57-66.
33. Yim E.K., Darling E.M., Kulangara K., Guilak F., Leong K.W. Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials 2010, 31:1299-1306.
34. Weiss J.N., Chen P.S., Qu Z., Karagueuzian H.S., Garfinkel A. Ventricular fibrillation: how do we stop the waves from breaking?. Circ Res 2000, 87:1103-1107.
35. Goldhaber J.I., Xie L.H., Duong T., Motter C., Khuu K., Weiss J.N. Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling. Circ Res 2005, 96:459-466.
36. Lee E.J., Kim do E., Azeloglu E.U., Costa K.D. Engineered cardiac organoid chamber: toward a functional biological model ventricle. Tissue Eng Part A 2008, 14:215-225.